ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Tomasi To Resign As Roswell Park President; Committee To Study NIH Grant Review Issues

December 15, 1995

Arnold Levine Named Professor At UMDNJ

February 28, 2003

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

In Brief: Five Institutions To Test Interferon; Appendectomy-Cancer Association Noted

October 27, 1978

DeVita, Moertel Debate Timing Of Levamisole Update

February 16, 1990

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007